Results 171 to 180 of about 1,097 (295)

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria. [PDF]

open access: yesMalar J, 2023
Mokuolu OA   +9 more
europepmc   +1 more source

Tissue‐Specific and Spatially Dependent Metabolic Signatures Perturbed by Injury in Male and Female Mice

open access: yesArthritis &Rheumatology, EarlyView.
Objective Osteoarthritis, the leading cause of disability worldwide, disproportionately affects women, yet sex remains an overlooked determinant. This disparity stems from sex‐specific differences in injury susceptibility—a major risk factor for disease.
Hope D. Welhaven   +6 more
wiley   +1 more source

A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

open access: yesArthritis &Rheumatology, EarlyView.
Objective The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory ...
Yvonne M. Mueller   +16 more
wiley   +1 more source

NiFe‐NO3 Layered Double Hydroxide as a Novel Anode for Sodium Ion Batteries

open access: yesBatteries &Supercaps, Volume 8, Issue 3, March 2025.
This study demonstrates, for the first time, the effectiveness of using LDH as an anodic material in SIB. The material is stable and show high specific capacity, the reaction mechanism has been thoroughly investigated and comprehensively described and involves a phase change reaction followed by sodium intercalation.
Marco Fortunato   +4 more
wiley   +1 more source

Multiple, Single Trait GWAS and Supervised Machine Learning Reveal the Genetic Architecture of Fraxinus excelsior Tolerance to Ash Dieback in Europe. [PDF]

open access: yesPlant Cell Environ
Doonan JM   +19 more
europepmc   +1 more source

Infusion rate adjustment in enzyme replacement therapy with pabinafusp alfa for mucopolysaccharidosis II

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Enzyme replacement therapy (ERT) for mucopolysaccharidosis II (MPS II) requires long‐term, weekly intravenous infusions often lasting over 3 h each time, which can burden paediatric patients and caregivers and negatively affect their quality of life and treatment compliance.
Kimitoshi Nakamura   +6 more
wiley   +1 more source

Hagadah shel Pesach Maaseh Alfas

open access: yes
Alfas, ben Tzion bar Yirmiyah Akiva   +1 more
core   +1 more source

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature. [PDF]

open access: yesInt J Environ Res Public Health, 2020
Halimi V   +5 more
europepmc   +1 more source

Alfa-D-Mannosidaasit ja Alfa-Mannosidoosi

open access: yes, 2018
Alfa-mannosidaasit ovat ryhmä entsyymejä jotka osallistuvat glykoproteiinien rakennukseen ja kierrätykseen leikkaamalla mannosidaasien välisiä alfa-sidoksia hydrolyysillä. Alfa-mannosidoosi on sairaus joka johtuu lysosomaalisen alfa-mannosidaasin mutaatioista. Sairauden vakavuus riippuu mutaation tyypistä ja sijainnista.
openaire   +1 more source

Home - About - Disclaimer - Privacy